Omega-3 Fatty Acids in Psychiatry

Psychiatric Clinics of North America

Volumn 36, Issue 1, 2013, Pages 15-23

  Mischoulon, David ^a   Freeman, Marlene P ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Bipolar disorder; Complementary and alternative medicine; Depression; Docosahexaenoic acid; Ethyl eicosapentaenoate; N 3; Omega 3

Indexed keywords

ACETYLSALICYLIC ACID; CLOZAPINE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; OMEGA 3 FATTY ACID; PLACEBO; SEROTONIN UPTAKE INHIBITOR; WARFARIN;

ANTIDEPRESSANT ACTIVITY; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; BLEEDING; BORDERLINE STATE; CHILDHOOD DISEASE; CLINICAL EFFECTIVENESS; DIET SUPPLEMENTATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GASTROINTESTINAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; OBSESSIVE COMPULSIVE DISORDER; PEDIATRICS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PUERPERAL DEPRESSION; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; TREATMENT RESISTANT DEPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); DRUG COMBINATION; MENTAL DISORDERS;

CLINICAL TRIALS AS TOPIC; DOCOSAHEXAENOIC ACIDS; DRUG THERAPY, COMBINATION; EICOSAPENTAENOIC ACID; HUMANS; MENTAL DISORDERS;

EID: 84875610768     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2012.12.002     Document Type: Review

References (10)

1. Stoll A.L. Omega-3 fatty acids in mood disorders: a review of neurobiological and clinical actions. Natural medications for psychiatric disorders: considering the alternatives 2008, 39-67. Lippincott Williams & Wilkins, Philadelphia. D. Mischoulon, J. Rosenbaum (Eds.).
2. Freeman M.P., Hibbeln J.R., Wisner K.L., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatr 2006, 67:1954-1967.
3. Lin P.Y., Su K.P. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. J Clin Psychiatry 2007, 68(7):1056-1061.
4. Sublette M.E., Ellis S.P., Geant A.L., et al. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry 2011, 72(12):1577-1584.
5. Greenberg J.A., Bell S.J., Ausdal W.V. Omega-3 fatty acid supplementation during pregnancy. Rev Obstet Gynecol 2008, 1(4):162-169.
6. Sarris J., Mischoulon D., Schweitzer I. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. J Clin Psychiatry 2012, 73(1):81-86.
7. Parker G., Gibson N.A., Brotchie H., et al. Omega-3 fatty acids and mood disorders. Am J Psychiatry 2006, 163(6):969-978.
8. Montgomery P., Richardson A.J. Omega-3 fatty acids for bipolar disorder. Cochrane Database Syst Rev 2008, (2). CD005169.
9. Bloch M.H., Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry 2011, 50(10):991-1000.
10. Appleton K.M., Rogers P.J., Ness A.R. Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. Am J Clin Nutr 2010, 91(3):757-770.